THURSDAY, July 29, 2021 (HealthDay News) — Children diagnosed with type 2 diabetes face a high likelihood of developing complications before age 30, a new study suggests. Researchers found that among 500 children and teenagers with type 2 diabetes, 60% developed at least one complication over the next 15 yearsContinue Reading

TUESDAY, July 27, 2021 (HealthDay News) — While efforts to develop Alzheimer’s medications have so far borne little fruit, new research highlights the therapeutic promise of two non-drug tools: light and sound. According to a pair of small new studies, exposing Alzheimer’s patients to an hour a day of carefullyContinue Reading

MONDAY, July 26, 2021 (HealthDay News) — Young soccer players have more head impacts during practices but experience more severe head impacts during games, a small, preliminary study shows. The findings could help devise ways to improve head impact safety in youth soccer, according to the researchers. “Headers are aContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — The controversial new Alzheimer’s drug Aduhelm is creating something of a civil war in medicine, as health networks, hospitals, insurers and individual doctors weigh impending discussions with patients about whether they should take the medication. Many doctors believe the U.S. Food and DrugContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — A drug that eases hallucinations in people with Parkinson’s disease may be able to do the same for those with dementia, a new clinical trial finds. The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and delusionsContinue Reading